LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

Trial Identifier:	D133HR00044
Sponsor:	AstraZeneca
Start Date:	August 2025
Primary Completion Date:	September 2027
Study Completion Date:	September 2027
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Canada, Alberta	Calgary, Alberta, Canada, T2N1N4
Canada, Ontario	Toronto, Ontario, Canada, M5T3M6

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.